InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Wednesday, 08/14/2019 7:17:03 AM

Wednesday, August 14, 2019 7:17:03 AM

Post# of 425942
I am beginning to think R-IT results made it impossible to request minimal label expansion. Meaning, in the interests of shareholders and in light of R-IT data, AMRN felt it necessary to ask for a much more expanded label and then the FDA felt it couldn’t sign off on it without conducting an ADCOM to cover its you-know-what. Must be very frustrating for management.

I remain long and strong. Still picking up shares when I can. Nothing has taught me the value of patience more than this long long ride with AMRN.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News